Egfr-mutant Lung Cancers
📧 Sign up to get email alerts when something new happens for Egfr-mutant Lung Cancers.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating osimertinib plus bevacizumab in EGFR-mutant non-small cell lung cancer has completed with results posted.